Mindfulness-Based Education on Sexual/Reproductive Health Stigma and Self-Esteem in Female University Students

February 1, 2026 updated by: EDA OZYON ETLI

The Effect of Mindfulness-Based Education Given to Female University Students on Sexual/Reproductive Health Stigma and Self-Esteem: a Randomized Controlled Study

This study was conducted to determine the effect of a mindfulness-based education program on mindfulness level, reproductive and sexual health stigma, and self-esteem among young women.

Study Overview

Detailed Description

The research was designed as a quasi-experimental pretest-posttest control group study. The experimental group received a 4-week "Mindfulness-Based Education Program" with one session per week. Data were collected using the Personal Information Form, the Mindfulness Scale (MS), the Young Women's Reproductive and Sexual Health Stigma Scale (YWRSHSS), and the Rosenberg Self-Esteem Scale (RSES). Follow-up measurements were conducted one and three months after the training.

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beylikduzu
      • Istanbul, Beylikduzu, Turkey (Türkiye), 34528
        • Istanbul Beykent University.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Female students aged 18 years and older
  • Enrolled in a vocational school of health services
  • Volunteering to participate in the study
  • Fluent in speaking and understanding Turkish

Exclusion Criteria:

  • Female students pursuing a second university degree
  • Students currently receiving mindfulness training or sexual health education outside of the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mindfulness-Based Education Group
Participants in this group receive a mindfulness-based education program designed to increase awareness related to sexual and reproductive health, reduce stigma, and improve self-esteem. The program is delivered through structured educational sessions conducted over a defined period.
The intervention consists of a 4-week structured mindfulness-based education program. Participants in the experimental group attend one 60-minute session per week. The program covers mindfulness meditation, body scan techniques, and cognitive exercises focused on reducing sexual/reproductive health stigma and enhancing self-esteem
Other Names:
  • Mindfulness-Based Stress Reduction
No Intervention: Control Group
Participants in the control group do not receive any intervention and continue with their usual routine during the study period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Mindfulness Attention Awareness Scale (MAAS) Score
Time Frame: Baseline, Post-intervention (4th week), 1st-month follow-up, and 3rd-month follow-up
Total score from the Mindfulness Attention Awareness Scale. It consists of 15 items. Higher scores indicate higher levels of dispositional mindfulness.
Baseline, Post-intervention (4th week), 1st-month follow-up, and 3rd-month follow-up
Change in Young Women's Reproductive and Sexual Health Stigma Scale (YWRSHSS) Score
Time Frame: Baseline, Post-intervention (4th week), 1st-month follow-up, and 3rd-month follow-up
Total score from the Young Women's Reproductive and Sexual Health Stigma Scale. It consists of 20 items. Scores range from 0 to 20, where higher scores indicate higher levels of perceived stigma
Baseline, Post-intervention (4th week), 1st-month follow-up, and 3rd-month follow-up
Change in Rosenberg Self-Esteem Scale (RSES) Score
Time Frame: Baseline, Post-intervention (4th week), 1st-month follow-up, and 3rd-month follow-up
Total score from the Rosenberg Self-Esteem Scale (Short Form). It consists of 20 items assessing self-worth. Higher scores represent more positive self-esteem.
Baseline, Post-intervention (4th week), 1st-month follow-up, and 3rd-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Emel E EGE, Prof. Dr., Necmettin Erbakan University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 27, 2024

Primary Completion (Actual)

March 19, 2025

Study Completion (Actual)

April 17, 2025

Study Registration Dates

First Submitted

January 5, 2026

First Submitted That Met QC Criteria

February 1, 2026

First Posted (Actual)

February 3, 2026

Study Record Updates

Last Update Posted (Actual)

February 3, 2026

Last Update Submitted That Met QC Criteria

February 1, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified individual participant data (IPD) that underlie the results reported in this study may be shared with researchers upon reasonable request via email to the corresponding author.

IPD Sharing Time Frame

Data will be available after the study results are published and for a period of up to 5 years.

IPD Sharing Access Criteria

Researchers must provide a clear research objective and sign a data access agreement.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mindfulness

Clinical Trials on Mindfulness-Based Education Program

Subscribe